Susan M. Cheer

Octreotide long-acting release (LAR): a review of its use in the management of acromegaly.

Kate McKeage, Susan M. Cheer, Antona J. Wagstaff
Drugs
2003

Octreotide long-acting release (LAR) is a somatostatin analogue designed for once monthly intramuscular injection. As with endogenous somatostatin, octreotide LAR inhibits secretion of growth hormone… (More)

Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.

Susan M. Cheer, Greg L. Plosker
American journal of clinical dermatology
2001

UNLABELLED Tacrolimus, a macrolide immunomodulator, is believed to control atopic dermatitis by inhibiting T lymphocyte activation, altering cell surface expression on antigen-presenting dendritic… (More)

Ropinirole: for the treatment of restless legs syndrome.

Susan M. Cheer, Lynne M. Bang, Gillian M. Keating
CNS drugs
2004

Ropinirole is a non-ergoline dopamine agonist that exhibits a high affinity for D(2) and D(3) receptors but little or no affinity for D(1)-like and non-dopaminergic receptors. Symptoms of restless… (More)

Tinzaparin sodium: a review of its pharmacology and clinical use in the prophylaxis and treatment of thromboembolic disease.

Susan M. Cheer, Christopher J. Dunn, Rachel H. Foster
Drugs
2004

Tinzaparin sodium (tinzaparin; innohep) is a low molecular weight heparin (LMWH) formed by the enzymatic degradation of porcine unfractionated heparin (UFH). In clinical trials, once-daily… (More)

Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.

Susan M. Cheer, John L. T. Waugh, Stuart Noble
Drugs
2003

Specifically formulated for nebulisation using the PARI LC PLUS reusable nebuliser, tobramycin solution for inhalation (TSI) [TOBI] provides a high dose of tobramycin (an aminoglycoside antibacterial… (More)

Quetiapine. A review of its use in the management of schizophrenia.

Quetiapine (Seroquel), a dibenzothiazepine derivative, is an atypical antipsychotic with demonstrated efficacy in acute schizophrenia. In short-term, randomised, double-blind trials, it was usually… (More)

Paroxetine: an update of its use in psychiatric disorders in adults.

Antona J. Wagstaff, Susan M. Cheer, Anna J. Matheson, Douglas Ormrod, Karen L. Goa
Drugs
2002

Paroxetine is a selective serotonin reuptake inhibitor (SSRI), with antidepressant and anxiolytic activity. In 6- to 24-week well designed trials, oral paroxetine 10 to 50 mg/day was significantly… (More)

Spotlight on paroxetine in psychiatric disorders in adults

Antona J. Wagstaff, Susan M. Cheer, Anna J. Matheson, Douglas Ormrod, Karen L. Goa
CNS drugs
2002

Paroxetine is a selective serotonin reuptake inhibitor (SSRI), with antidepressant and anxiolytic activity. In 6- to 24-week well designed trials, oral paroxetine 10 to 50 mg/day was significantly… (More)

Spotlight on Fluvoxamine in Anxiety Disorders in Children and Adolescents

Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) which may be used for the management of anxiety disorders in children and adolescents. Absorption of fluvoxamine was similar in… (More)

Pantoprazole for the Treatment of Peptic Ulcer Bleeding and Prevention of Rebleeding

Christo J. van Rensburg, Susan M. Cheer
Clinical medicine insights. Gastroenterology
2012

Adding proton pump inhibitors (PPIs) to endoscopic therapy has become the mainstay of treatment for peptic ulcer bleeding, with current consensus guidelines recommending high-dose intravenous (IV)… (More)

Filter Results:

Publication Year

Publication Type

Co-author

Journals and Conferences